Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta?

Area of Science:

• Regenerative Medicine
• Genetics
• Orthopedics

Background:

• Osteogenesis imperfecta (OI) is a genetic disorder causing brittle bones due to defective type I collagen.
• OI presents with severe bone deformities, growth issues, and frequent fractures, with varying clinical severity.
• Prenatal diagnosis is possible for more severe forms of OI.

Purpose of the Study:

• To review current knowledge on mesenchymal stem cell (MSC) transplantation for osteogenesis imperfecta (OI).
• To evaluate the safety and efficacy of prenatal and postnatal MSC transplantation in OI treatment.

Main Methods:

• Review of preclinical and clinical studies on MSC transplantation in OI models and patients.
• Analysis of reported outcomes regarding bone structure, growth, mobility, and fracture incidence.

Main Results:

• MSC transplantation demonstrated safety and positive effects in OI treatment.
• Observed improvements include enhanced linear growth, increased mobility, and reduced fracture rates.
• The therapeutic effects of MSC transplantation were found to be transient, potentially requiring repeat procedures.

Conclusions:

• MSC transplantation holds potential for improving OI management, offering temporary benefits.
• Limited clinical experience necessitates further rigorous studies to establish definitive clinical utility.
• Re-transplantation strategies may be required to sustain therapeutic effects in OI patients.